跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOXICLAV 625 TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
MOXICLAV 625 TABLET
Approved
THERAPEUTIC
MOXICLAV 625 TABLET
Medochemie Ltd – Factory B
🇸🇬 Health Sciences Authority
Approval Date
Jan 20, 1999
Approval ID
a14c6caa5609f993
Company
Medochemie Ltd – Factory B
Type
Therapeutic
Approval Details
Approval Id
a14c6caa5609f993
Drug Name
MOXICLAV 625 TABLET
Product Name
MOXICLAV 625 TABLET
Approval Number
SIN10689P
Approval Date
1999-01-20
Registrant
MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder
MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01CR02
Atc Item Name
amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name
MEDOCHEMIE SINGAPORE PTE. LTD.
Company Detail Path
/organization/medochemie-singapore-pte-ltd
Active Ingredients
CLAVULANATE POTASSIUM + MICROCRYSTALLINE CELLULOSE EQV TO CLAVULANIC ACID
125 mg
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
500 mg
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
500 MG
CLAVULANATE POTASSIUM + MICROCRYSTALLINE CELLULOSE EQV TO CLAVULANIC ACID
125 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 20, 1999
Approval ID
a14c6caa5609f993
Type
Therapeutic
Back to HSA Approvals